Naloxone, an opiate receptor antagonist, ameliorates acute experimental autoimmune myocarditis by reducing cytotoxic activities

Journal of Cardiovascular Pharmacology

Volumn 52, Issue 5, 2008, Pages 445-451

  Kishimoto, Chiharu ^a   Okabe, Taka Aki ^a   Hattori, Miki ^a   Yuan, Zuyi ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Autoimmune myocarditis; Cytotoxic activities; Naloxone; Opiate system

Indexed keywords

ADRENALIN; BETA ENDORPHIN; CARDIAC MYOSIN; GAMMA INTERFERON; INTERLEUKIN 1BETA; INTERLEUKIN 4; NALOXONE; NORADRENALIN; OPIATE; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE; NARCOTIC ANTAGONIST;

ACUTE DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; CHROMIUM 51 RELEASE; CHRONIC DISEASE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DRUG ACTIVITY; HEART MUSCLE INJURY; HEMODYNAMICS; HISTOPATHOLOGY; HYPOTENSION; MOUSE; MYOCARDITIS; NONHUMAN; ORGAN WEIGHT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TUMOR CELL; ANIMAL; BLOOD; C57BL MOUSE; CYTOTOXICITY; CYTOTOXICITY TEST; DISEASE MODEL; DRUG EFFECT; ERYTHROCYTE; HEART MUSCLE; IMMUNOLOGY; METABOLISM; PATHOLOGY; RADIOIMMUNOASSAY; TUMOR CELL LINE;

ACUTE DISEASE; ANIMALS; AUTOIMMUNE DISEASES; BETA-ENDORPHIN; CELL LINE, TUMOR; CYTOKINES; CYTOTOXICITY TESTS, IMMUNOLOGIC; CYTOTOXICITY, IMMUNOLOGIC; DISEASE MODELS, ANIMAL; ERYTHROCYTES; MICE; MICE, INBRED C57BL; MYOCARDITIS; MYOCARDIUM; NALOXONE; NARCOTIC ANTAGONISTS; RADIOIMMUNOASSAY;

EID: 59449096436     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/FJC.0b013e31818c8605     Document Type: Article

References (29)

1. Feldman AM, McNamara D. Myocarditis. New Engl J Med. 2000;343: 1388-1398.
2. Liu PP, Mason JW. Advances in the understanding of myocarditis. Circulation. 2001;104:1076-1082.
3. Smith SC, Allen PM. Myosin-induced acute myocarditis is a T cell-mediated disease. J Immunol. 1991;147:2141-2147.
4. Kodama M, Matsumoto Y, Fujiwara M. In vivo lymphocyte mediated myocardial injuries demonstrated by adoptive transfer of experimental autoimmune myocarditis. Circulation. 1992;85: 1918-1926.
5. Armstrong DW, Hatfield BD. Hormonal responses to opioid receptor blockade: during rest and exercise in cold and hot enviroments. Eur J Appl Physiol. 2006;97:43-51.
6. Litschaner B, Schaller G, Wolzt M. Naloxone does not influence cardiovascular responses to mild mental stress in postmenopausal women. Am J Physiol. 2005;289:H2120-H2125.
7. Kishimoto C, Takada H, Hiraoka Y, et al. Effects of naloxone, an opiate receptor antagonist, on coxsackievirus B3 myocarditis in the mouse. Cardiovasc Res. 1995;29:80-84.
8. Shioji K, Kishimoto C, Nakamura H, et al. Upregulation of thioredoxin (TRX) expression in giant cell myocarditis in rats. FEBS Lett. 2000;472: 109-113.
9. Shioji K, Kishimoto C, Sasayama S. Fc receptor-mediated inhibitory effect of immuoglobulin therapy on autoimmune giant cell myocarditis: concominant suppression of the expression of dendritic cells. Circ Res. 2001;89:540-546.
10. Kishimoto C, Takada H, Kawamata H, et al. Immunoglobulin treatment prevents congestive heart failure in murine encephalomyocarditis viral myocarditis associated with reduction of inflammatory cytokines. J Pharmacol Exp Ther. 2001;299:645-651.
11. Takada H, Kishimoto C, Hiraoka Y, et al. Captopril suppresses interstitial fibrin deposition in coxsackievirus B3 myocarditis. Am J Physiol. 1997; 272:H211-H219.
12. Yuan Z, Kishimoto C, Shioji K. Beneficial effects of low-dose benidipine in acute autoimmune myocarditis. Suppressive effects on inflammatory cytokines and inducible nitric oxide synthase. Circulation J. 2003;67: 545-550.
13. 1 antagonist, suppresses cytotoxic myocardial injury in autoimmune heart failure. Am J Physiol. 2005;289:H1147-1152.
14. Guillemin R, Ling N, Vargo T. Radioimmunoassays for α-endorphin and β-endorphin. Biochem Biophys Res Commun. 1977;77:361-336.
15. Kishimoto C, Takamatsu, N, Kawamata H, et al. Immunoglobulin treatment ameliorates murine myocarditis with reduction of neurohumoral activity and improvement of extracellular matrix. J Am Coll Cardiol. 2000;36:1979-1984.
16. Shioji K, Kishimoto C, Nakayama Y, et al. Strain difference in rats with experimental giant cell myocarditis. Jpn Circ J. 2000;64:283-286.
17. Frustaci A, Cuoco L, Chimenti C, et al. Celiac disease associated with autoimmune myocarditis. Circulation. 2002;105:2611-2618.
18. Kaur M, Liguori A, Fleischer AB Jr, et al. Plasma beta-endorphin levels in frequent and infrequent tanners before and after ultraviolet and non-ultraviolet stimuli. J Am Acad Dermatol. 2006;54:919-920.
19. Irwin M, Hauger RL, Brown M, et al. CRF activates autonomic nervous system and reduces natural killer cytotoxicity. Am J Physiol. 1988;255: R744-R747.
20. Nishii M, Inomata T, Niwano H, et al. β2-adrenergic agonists suppress rat autoimmune myocarditis. Potential role of β2-adrenergic stimulants as new therapeutic agents for myocarditis. Circulation. 2006;114: 936-944.
21. Tachikawa H, Kodama M, Watanabe K, et al. Amiodarone improves cardiac sympathetic nerve function to hold norepinephrine in the heart, prevents left ventricular remodeling, and improves cardiac function in rat dilated cardiomyopathy. Circulation. 2005;111:894-899.
22. Flierl MA, Rittirsch D, Nadeau BA, et al. Phagocyte-derived catecholamines enhance acute inflammatory injury. Nature. 2007;449: 721-725.
23. Shakhar G, Ben-Eliyahu S. In vivo β-adrenergic stimulation suppresses natural killer activity and compromises resistance to tumor metastasis in rats. J Immunol. 1998;160:3251-3258.
24. Sakamoto S, Stone CK, Woolf PD, et al. Opiate receptor antagonism in right-sided congestive heart failure: Naloxone exerts salutary hemody-namic effects through its action on the central nervous system. Circ Res. 1989;65:103-114.
25. Imai N, Kashiki M, Woolf PD, et al. Comparison of cardiovascular effects of μ- and δ-opioid receptor antagonists in dogs with congestive heart failure. Am J Physiol. 1994;267:H912-H917.
26. Fontana F, Bernardi P, Pich EM, et al. Endogenous opioid peptides and mental stress in congestive heart failure patients. Peptides. 1998;19:21-26.
27. Yatani A, Imai N, Himura Y, et al. Chronic opiate-receptor inhibition in experimental congestive heart failure in dogs. Am J Physiol. 1997;272:H478-H484.
28. Litschauer B, Schaller G, Wolzt M. Naloxone does not influence cardiovascular responses to mild mental stress in postmenopausal women. Am J Physiol. 2005;289:H2120-H2125.
29. Gao J, Chua CC, Yin D, et al. Cardiac dysfunction induced by chronic restrain stress is mediated by opioid receptors [Abstract]. Circulation. 2007;116(II):741-742.